πŸ‡ΊπŸ‡Έ FDA
Patent

US 11040109

Blood coagulation protein conjugates

granted A61KA61K38/37A61K38/4846

Quick answer

US patent 11040109 (Blood coagulation protein conjugates) held by Takeda Pharmaceutical Company Limited expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K38/37, A61K38/4846, A61K47/60, A61K47/61